Last update 29 Nov 2024

HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital )

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
Exosomes derived from human umbilical cord blood mesenchymal stem cells(Xuanwu Hospital), Extracellular Vesicles HUC-MSC-sEV-001(Xuanwu Hospital)
Target-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseOther Diseases
Active Indication
Amyotrophic Lateral SclerosisAlzheimer DiseaseLewy Body Disease+ [2]
Inactive Indication-
Originator Organization
Xuanwu Hospital Capital Medical University
Active Organization
Xuanwu Hospital Capital Medical University
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital )
NCT06598202 / RecruitingPhase 1/2IIT
An Exploratory Study on the Use of Intranasal Administration of Small Extracellular Vesicles for the Treatment of Amyotrophic Lateral Sclerosis
NCT06607900 / Not yet recruitingPhase 1IIT
A Multi-center, Open, Single-arm, Basket-design Clinical Trial to Evaluate the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles HUC-MSC-sEV-001 Nasal Drops for the Treatment of Multiple Neurodegenerative Diseases
100 Clinical Results associated with HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital )
Login to view more data
100 Translational Medicine associated with HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital )
Login to view more data
100 Patents (Medical) associated with HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital )
Login to view more data
100 Deals associated with HUC-MSC-sEV-001 Nasal Drops(Xuanwu Hospital )
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Amyotrophic Lateral SclerosisPhase 2
CN
Xuanwu Hospital Capital Medical University
01 Dec 2024
Alzheimer DiseasePhase 1
CN
Xuanwu Hospital Capital Medical University
01 Nov 2024
Lewy Body DiseasePhase 1
CN
Xuanwu Hospital Capital Medical University
01 Nov 2024
Multiple System AtrophyPhase 1
CN
Xuanwu Hospital Capital Medical University
01 Nov 2024
Parkinson DiseasePhase 1
CN
Xuanwu Hospital Capital Medical University
01 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free